periplogenin has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Omari-Siaw, E; Tong, SS; Wang, Y; Wang, YW; Xu, WQ; Xu, XM; Yu, JN; Zhang, HY; Zheng, YY | 1 |
1 other study(ies) available for periplogenin and Neoplasms
| Article | Year |
|---|---|
Tumor targeted delivery of octreotide-periplogenin conjugate: Synthesis, in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Digitoxigenin; Drug Delivery Systems; Humans; Male; Mice; Neoplasms; Octreotide; Tissue Distribution; Tumor Burden | 2016 |